bioMérieux - 2011 Business Review

24 January, 2012

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for fourth-quarter and full-year 2011.

Net sales for the year amounted to €1,427 million, up 5.2% from the €1,357 million generated in 2010. This represented a year-on-year increase of 6.5% at constant exchange rates, including 4.1% growth at constant exchange rates and comparable business base (i.e. excluding the impact of recent acquisitions and of discontinuing culture media for routine clinical testing in North America).

Lifted by a very good December, fourth-quarter organic sales rose by 4.5%, led in particular by strong instrument sales in emerging markets.

  • Sales:
    • Up 6.5% at constant exchange rates
    • Including 4.1% organic growth
  • Double-digit growth* in 11 countries
  • Including: India** (up 28%), China (up 20%), Brazil (up 18%) and Turkey (up 18%)
  • Sustained momentum in clinical microbiology, up 8.2%*
  • Instrument sales up a robust 7.9%*

* At constant exchange rates and comparable business base
** Excluding the impact of the termination of a distribution contract for non-strategic products

Download the Full Report:

Pioneering Diagnostics